Blau Farmacêutica Balance Sheet

Financials in millions BRL. Fiscal year is January - December.

Millions BRL. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	56.29	45.6	33.32	31.5	14.11	51.86
Short-Term Investments	485.9	-	-	375.82	629.53	870.96
Trading Asset Securities	-	569.49	459.56	-	-	-
Cash & Short-Term Investments	542.18	615.09	492.87	407.31	643.65	922.82
Cash Growth	22.64%	24.80%	21.00%	-36.72%	-30.25%	330.52%
Accounts Receivable	472.89	458.47	476.75	453.56	420.61	331.79
Other Receivables	136.72	129.54	42.5	64.35	44.58	13.66
Receivables	609.6	588.02	519.25	517.91	465.19	345.45
Inventory	676.13	694.13	606.19	628.65	569.02	416.85
Other Current Assets	-	-	57.85	-	-	11.35
Total Current Assets	1,828	1,897	1,676	1,554	1,678	1,696
Property, Plant & Equipment	1,002	997.08	829.04	738.71	542.48	371.58
Long-Term Investments	-	-	265.16	265.19	-	0.04
Goodwill	-	151.66	151.66	151.66	143.24	143.24
Other Intangible Assets	633.54	67.86	53.81	24.83	16.57	5.75
Long-Term Deferred Tax Assets	73	77.8	84.52	81.53	-	-
Long-Term Deferred Charges	-	397.6	282.28	177.58	74.25	49.82
Other Long-Term Assets	37.62	45.81	69.12	60.17	44.65	61.14
Total Assets	3,574	3,635	3,412	3,054	2,499	2,328
Accounts Payable	199.61	266.38	286	179.92	163.64	116.43
Accrued Expenses	85.29	89.21	90.21	55.62	56.78	55.2
Short-Term Debt	69.63	94.49	1.87	2.3	-	41.73
Current Portion of Long-Term Debt	173.96	184.03	65.1	67.92	79.87	49.82
Current Portion of Leases	6.33	7.07	6.39	4.8	3.67	2.11
Current Income Taxes Payable	7.65	0.03	8.92	-	19.44	19.99
Other Current Liabilities	145.31	127.24	79.46	25.38	47.71	57.72
Total Current Liabilities	687.78	768.45	537.94	335.93	371.11	343.01
Long-Term Debt	283.33	283.33	450	500	200	272.5
Long-Term Leases	27.03	30.21	35.59	33.52	28.17	8.35
Long-Term Deferred Tax Liabilities	226.39	221.98	170.2	125.64	35.02	18.25
Other Long-Term Liabilities	74.1	75.32	67.33	63.2	46.81	51.05
Total Liabilities	1,299	1,379	1,261	1,058	681.11	693.16
Common Stock	1,717	1,717	1,317	1,317	1,317	1,317
Retained Earnings	634.55	612.28	899.32	744.37	562.8	325.13
Treasury Stock	-42.84	-42.89	-42.89	-42.89	-39.9	-
Comprehensive Income & Other	-14.63	-14.23	-9.05	-16.62	-17.36	-5.45
Total Common Equity	2,294	2,272	2,164	2,001	1,822	1,636
Minority Interest	-18.61	-16.02	-13.33	-6.22	-4.22	-1.4
Shareholders' Equity	2,275	2,256	2,151	1,995	1,818	1,635
Total Liabilities & Equity	3,574	3,635	3,412	3,054	2,499	2,328
Total Debt	560.29	599.13	558.95	608.54	311.71	374.52
Net Cash (Debt)	-18.1	15.95	-66.08	-201.22	331.93	548.3
Net Cash Growth	-	-	-	-	-39.46%	-
Net Cash Per Share	-0.08	0.07	-0.29	-0.87	1.44	2.35
Filing Date Shares Outstanding	230.98	230.98	230.98	230.98	231.18	233.21
Total Common Shares Outstanding	230.98	230.98	230.98	230.98	231.18	233.21
Working Capital	1,140	1,129	1,138	1,218	1,307	1,353
Book Value Per Share	9.93	9.84	9.37	8.66	7.88	7.02
Tangible Book Value	1,660	2,052	1,959	1,825	1,662	1,487
Tangible Book Value Per Share	7.19	8.88	8.48	7.90	7.19	6.38
Machinery	-	440.23	338.57	302.14	170.92	135.22
Construction In Progress	-	335.21	296.26	257.03	210.19	194.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.